GGrantIndex
← Search

IDENTIFICATION AND ASSESSMENT OF TARGETS FOR IMMUNOTHERAPY IN NF2-ASSOCIATED SCHWANNOMATOSIS

$968,875FY2025Defense Health AgencyDOD

H. Lee Moffitt Cancer Center And Research Institute Hospital, Inc.

Investigators

View source on USAspending →
IDENTIFICATION AND ASSESSMENT OF TARGETS FOR IMMUNOTHERAPY IN NF2-ASSOCIATED SCHWANNOMATOSIS · GrantIndex